Analysis of immunogenicity data in the product information of biological drugs: a need to report immunogenicity data systematically
<p><strong>Objective</strong> The aim of this analysis was to evaluate whether the current unsystematic assessment leads to sufficient reporting of immunogenicity-related information in the Summary of Product Characteristics (SmPCs) of biological products approved in the European m...
Main Authors: | Borrega, R, Cruz, J, Taylor, P, Goncalves, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2019
|
Similar Items
-
Biosimilars: an opportunity to update the product information of biological drugs regarding their immunogenicity
by: Borrega, R, et al.
Published: (2019) -
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
by: Fernando Valenzuela, et al.
Published: (2021-10-01) -
Preventing the immunogenicity of biological therapies
by: Somerfield, J, et al.
Published: (2011) -
The problems of THE immunogenicity of biologicals: theory and practice
by: D E Karateyev
Published: (2009-03-01) -
Immunogenicity of biologics in inflammatory bowel disease
by: Séverine Vermeire, et al.
Published: (2018-01-01)